A new study by investigators from Mass General Brigham finds that nearly 1 in 3 U.S. adults without heart disease—and almost ...

A short walk after dinner may support healthy cholesterol and heart health. Limiting late-night snacks can help support healthy cholesterol levels by reducing saturated fat and added sugar intake.

INDIANAPOLIS — Eli Lilly says Phase 1b of their Heart-2 trial, showed a reduction in the PCSK9 gene, linked to high cholesterol, following a single infusion. The PCSK9 gene binds to low-density ...

You can help yourself to lower cholesterol naturally, without medication, by eating the right foods. Cardiologists say a healthy diet is one of the best ways to protect heart health, in addition to ...

A single infusion of a gene-editing therapy called VERVE-102, which targets PCSK9 production in the liver, shows promise for lowering LDL cholesterol in patients with heterozygous familial ...

Add Yahoo as a preferred source to see more of our stories on Google. Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said.

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a positive start in an early clinical trial. Researchers running a Phase I ...

©2026 Fox News Network, LLC. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. All market data delayed 20 minutes.

Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up to 62% with a single infusion. Not only was the experimental treatment successful, but ...

Eli Lilly (LLY) announced that its gene editing candidate VERVE-102, added from its $1.3B acquisition of Verve Therapeutics last year, caused up to a 62% average decline in low-density lipoprotein ...

Eli Lilly said it received positive results from its phase 1b clinical trials for its experimental gene editing treatment for high cholesterol. The pharmaceutical company said Monday that a single ...